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The effects of Alzheimer's disease (AD) and ageing on blood–brain barrier (BBB)
breakdown are investigated in TgF344-AD and wild-type rats aged 13, 18 and
21 months. Permeability surface area products of the BBB to water (PSw) and
gadolinium-based contrast agent (PSg) were measured in grey matter using multiflip
angle multiecho dynamic contrast-enhanced MRI. At 13 months of age, there was no
significant difference in PSw between TgF344-AD and wild-types (p = 0.82). Between
13 and 18 months, PSw increased in TgF344-AD rats (p = 0.027), but not in wild-
types (p = 0.99), leading to significantly higher PSw in TgF344-AD rats at 18 months,
as previously reported (p = 0.012). Between 18 and 21 months, PSw values increased
in wild-types (p = 0.050), but not in TgF344-AD rats (p = 0.50). These results indicate
that BBB water permeability is affected by both AD pathology and ageing, but that
changes occur earlier in the presence of AD pathology. There were no significant
genotype or ageing effects on PSg (p > 0.05). In conclusion, we detected increases in
BBB water permeability with age in TgF344-AD and wild-type rats, and found that
changes occurred at an earlier age in rats with AD pathology.
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1 | INTRODUCTION
Gathering evidence now supports age-related blood–brain barrier (BBB) breakdown,1–3 particularly in the hippocampus,4 a region commonly asso-
ciated with early pathogenesis of Alzheimer's disease (AD). The BBB is further impaired in patients with early and established AD,5,6 including
increased blood–brain leakage of blood-derived proteins in the hippocampus and cortex,7,8 altered expression of BBB amyloid-β transporters in
the hippocampus,9–11 loss of pericytes,4,12 decreased expression of tight junction proteins in the hippocampus and cortex,13–15 blocked or dys-
functional interstitial drainage pathways16,17 and altered astrocytic aquaporin-4 expression.18 A small number of in-vivo tracer studies also support
the presence of BBB breakdown, showing increased BBB permeation of MRI contrast agents in the hippocampus and cortex.4,12,19 The impact of
BBB dysfunction on brain health is increasingly recognised. Bowman et al. showed that BBB breakdown measured using the cerebrospinal fluid
(CSF) albumin index was linked to cognitive abilities in healthy older adults,20 and Nation et al. showed that BBB breakdown as measured using
dynamic contrast-enhanced MRI was associated with cognition in patients with early AD, independent of amyloid-β, tau and vascular risk
status.12
Despite many reports of BBB alterations in AD, the timescales of these changes, and how they differ compared with age-related BBB alter-
ations, are poorly understood. Rodent models of AD allow studies spanning the equivalent of approximately 20 human years from prodromal to
advanced AD to be performed in a much shorter timeframe (approximately 1–2 years) and enable assessment of purely AD and age-related
changes in the absence of vascular risk factors. In our previous work, we demonstrated that TgF344-AD rats aged 18 months exhibit higher BBB
water permeability relative to wild-types (WTs), which correlated with loss of the tight junction protein occludin-1. We also found that these
changes did not affect the leakage rate of gadolinium-based contrast agent,15 indicating that BBB impairment due to the AD genotype was
subtle.
In this study, we assess age- and AD-related BBB breakdown in TgF344-AD and WT rats using MRI at two additional time points (13 and
21 months) to aid understanding of the time course of AD-related changes with reference to the normal age-related trajectory. In statistical ana-
lyses, we combine this data with our previously published 18-month data, which was acquired using the same imaging protocol in a different col-
ony of TgF344-AD rats. We used multi- fllipangle multiecho dynamic contrast-enhanced (MFAME-DCE) MRI to noninvasively measure the BBB
permeability surface area products of water (PSw) and gadolinium-based contrast agent (PSg) to simultaneously study various degrees of BBB
alterations.
2 | MATERIALS AND METHODS
2.1 | Animals
Two male and two female WT Fischer and TgF344-AD rats with the APPswe and PS1Δe9 mutations were purchased from the laboratory of Prof
T. Town (University of Southern California) and were set up as breeding pairs, housed in the Biological Services Unit at the University of Manches-
ter. Genotyping was outsourced to Transnetyx. Experimental procedures were approved by the Preclinical Imaging Executive Committee of the
University of Manchester and carried out in accordance with the UK Animals (Scientific Procedures) Act 1986 and EU Directive 2010/63/EU for
animal experiments. Breeding, housing and husbandry details, as recommended by the ARRIVE guidelines,21 can be found in the supporting
information.
Rats aged 13.3 ± 0.6 months (13 TgF344-AD [four females {F}: nine males {M}]; 16 WT [10 F: six M]) and 21.3 ± 1.5 months (eight
TgF344-AD [three F: five M]; seven WT [four F: three M]) were scanned under anaesthesia (4% isoflurane for induction followed by 2.5% iso-
flurane for maintenance in 100% O2 at 1 L/min). To evaluate the effects of age on PSw and PSg more thoroughly, previously published MRI data
from 18-month-old rats from a different cohort were included in statistical analyses (seven TgF344-AD and five WT; all male).15 Animals from
both cohorts were bred and kept under identical conditions, and the MRI protocols and analyses were identical. Of the 29 TgF344-AD and WT
rats scanned at 13 months, 14 were rescanned at 21 months. Eight rats scanned at 13 months were scanned twice within 2 weeks to assess the
scan-rescan repeatability of MRI measures. The attrition of rats between the 13 and 21-month time points was because 14 rats were culled after
the 13-month time point for ex-vivo analyses (for further comments, see the Discussion section), not because of natural or disease-related
deaths.
2.2 | MRI
MFAME-DCE MRI was used to measure the BBB permeability surface area products to water (PSw) and a small molecular weight gadolinium-
based contrast agent (PSg). MRI scans were acquired on a Bruker Avance III console interfaced with an Agilant 7T 16-cm bore magnet. A Bruker
transmit-only resonator (T11070V3) was used for transmission and a Bruker rat brain surface coil (T11205V3) was used for signal reception. A
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high-resolution T2-RARE anatomic volume was acquired for the purpose of region of interest (ROI) segmentation, as described later. The scan
parameters were: TR/TE = 3188/11 ms, NEX = 2, voxel size = 0.12 × 0.12 × 1 mm3, and matrix size = 256 × 256 × 64. Native T1 was measured
using coronal variable flip angle 3D spoiled gradient echo (SPGR) scans with the following acquisition parameters: α = 10, 20, 40 and 60;
TR/TE = 100/2.1 ms, voxel size = 0.46 × 0.46 × 0.31 mm3, and matrix size: 64 × 64 × 96. T1 estimates were corrected for B1 inhomogeneity by
jointly fitting to volumes acquired with short and long TR, as previously reported.15,22 Coronal dynamic 3D SPGR volumes were acquired at a sin-
gle flip angle before and during intravenous injection of gadoteric acid (Dotarem, Guerbet). A dose of 0.5 mmol kg−1 was delivered though a 24G
catheter with an electronic pump at 1 mL min−1. The acquisition parameters for these volumes were: 15 volumes, α = 60; TR/TE = 20/2.1 ms,
voxel size = 0.46 × 0.46 × 0.31 mm3, and matrix size: 64 × 64 × 96. Following these scans, coronal multiecho 3D SPGR volumes were acquired at
multiple flip angles. The flip angle was varied to alter the sensitivity of MRI signals to BBB water-exchange to enable estimation of PSw, as previ-
ously reported.15 The acquisition parameters for these volumes were: 6 volumes per flip angle, α = 30, 40, 20, 10 and 80; TR = 100 ms,
ΔTE = 2.14 ms, 10 echoes, voxel size = 1 × 1 × 1 mm3, and matrix size: 32 × 32 × 30. To conclude the scan, a final set of five single-echo single
flip angle SPGR volumes were acquired with the same acquisition parameters as the first 15 dynamic volumes. The slab select direction
was placed along the superior–inferior direction to ensure nonselective excitation of magnetisation along the rostral-caudal direction to minimise
T1-related inflow effects.
2.3 | MRI analysis
MRI data were analysed at an ROI level to maximise signal-to-noise ratio (SNR). The Schwarz et al. atlas23 was used to define ROIs for the hippo-
campus, cortex, thalamus and striatum by pooling together smaller substructures contained within (see Table 1 for details of the substructures
included in each ROI). ROIs were extracted for each rat by registering the reference image from the Schwarz et al. rat brain atlas to the high-
resolution T2-RARE image.
23 This was done using the Insight Toolkit within the Advanced Normalisation Tools package. The associated label
image was then downsampled to the spatial resolution of the SPGR volumes. Voxels containing significant CSF were excluded from ROIs using a
mask calculated by thresholding the precontrast T1 maps at T1 less than 3 s.
For each rat, the four individual ROIs were averaged to form a composite grey matter ROI. Median MRI signals for the composite ROI, and
each individual ROI, were then extracted for model fitting. MRI signal and precontrast T1 in blood were extracted from the superior sagittal sinus
(SSS) for calculation of the blood concentration time course Cb(t), also known as the vascular input function (VIF). The SSS ROI was defined as fol-
lows: a slice containing the SSS was manually selected from the fourth postcontrast volume (SSS appears bright). A histogram of decay-corrected
signals from this slice was generated and voxels with signal in the 99th percentile from all voxels in the slice were selected to be included in the
ROI. Quality control checks were performed to ensure these voxels did indeed arise from the SSS, and not from other vessels in the brain. During
the multiple flip angle scans, the VIF was not measured directly, but inferred from a biexponential fit to Cb(t) measured from the single flip angle
data (Figure 1A).
To estimate PSg [mL min
−1 mL−1 ], the Patlak model was fit to the single flip angle data, assuming fast BBB water-exchange (PSw = ∞).24 In
the case of low-level BBB impairment, transfer of small molecular weight gadolinium-based MRI contrast agents across the BBB are permeability-
limited and PSg is equivalent to the contrast agent volume transfer constant K
trans.25 To estimate PSw (mL min
−1 mL−1), data with multiple flip
angles were first corrected for T2* decay by fitting an exponential decay model, leading to estimates of S(TE = 0). A two-site water-exchange
model described previously15 was then fit to estimates of S(TE = 0), assuming PSg = 0 mL min
−1 mL−1. Our previous work15 shows that bias intro-
duced into estimates of PSw by assuming PSg = 0 is small for PSg < 10
−3 mL min−1 mL−1. All model parameters were estimated by minimising the
TABLE 1 Scan-rescan coefficient of variation (%) for PSw and PSg, alongside a description of the regions of interest (ROIs) including their
mean size ± sd (number of voxels), mean volume ± sd (mm3), and the substructures used for pooling
ROI details
Scan-rescan coefficient
of variation (%)
ROI name
Size
(voxels)
Volume
(mm3) Pooled substructures PSw PSg
Composite
ROI
7013 ± 855 480 ± 58 Hippocampus, cortex, striatum and thalamus 14 8
Hippocampus 1476 ± 144 101 ± 9.8 Antero-dorsal, posterior, subiculum and ventral 23 13
Cortex 3452 ± 510 236 ± 35 Cingulate, entorhinal, frontal association, medial prefrontal, parietal
association, somatosensory, retrosplinal and temporal association cortices
38 23
Striatum 1246 ± 175 85 ± 12 Caudate putamen, globus pallidus 13 12
Thalamus 839 ± 141 57 ± 10 Dorsolateral, midline dorsal, ventromedial 14 19
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sum of squared residuals between the model and data using a Levenberg–Marquart optimisation algorithm in R (version 4.0.2). No blinding to
genotype or age was performed. Full details of MFAME-DCE MRI acquisition and analysis are described in Dickie et al.15
2.4 | Scan-rescan repeatability and estimation of within-group biological variability
Scan-rescan repeatability for composite and regional PSw and PSg estimates was calculated from 13-month scan-rescan data by computing the
coefficient of variation (CoV) of repeats using the root mean square method26:
CoVR =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
2n
X di
mi
 2s
where di are the differences between paired measurements, mi are the means of the paired measurements and n (= 8) is the number of pairs of
measurements. CoV estimates are given in Table 1.
Correlation and Bland–Altman analysis was performed across all regional estimates of PSw and PSg to determine the coefficient of determina-
tion (R2) and limits of agreement between repeat measures.
An estimate of variability in PSw and PSg attributable to biological differences between rats (CoVB) was calculated from scan 1 repeatability
data by assuming biological variance and variance associated with random measurement error add-in quadrature to equal the total within-group
variance (CoV2WÞ:
CoV2B =CoV
2
W−CoV
2
R
CoVW was estimated by computing the standard deviation of scan 1 measurements divided by the mean of these same measures.
F IGURE 1 Example superior sagittal sinus (SSS) vascular input function (VIF), regions of interest (ROIs) and model fits to MFAME-DCE MRI
data. (A) Example Cb(t) estimate and the corresponding biexponential fit used to define the VIF from the SSS. The biexponential fit was used to
infer blood contrast agent concentration during acquisition of multiflip angle data. The procedure of extracting a VIF was performed individually
for each rat to capture interindividual variability in cardiac output, renal clearance and total blood volume. (B) Example segmentations of
hippocampus, cortex, striatum and thalamus ROIs. These ROIs were combined to form a composite ROI for statistical analyses; (C) example two-
site water-exchange model fits to multiflip angle data yielding estimates of PSw; and (D) example Patlak model fits to single flip angle data yielding
estimates of PSg. SPGR, spoiled gradient echo
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2.5 | Statistical analysis
All statistical analyses were performed in R (version 4.0.2). Prior to statistical analysis, outliers greater than ± 2 standard deviations from group
means were removed (resulting in removal of approximately 6% of all data points), and tests for normality on the resulting distributions were per-
formed using Shapiro–Wilk tests. The null hypothesis that data was normally distributed was rejected in one of 12 groups (PSw in 13-month-old
WTs; p = 0.003). Because most groups (11/12) displayed normally distributed data, parametric tests were used in further analyses.
The effects of AD and age on composite ROI PSw and PSg were assessed using a mixed-effects model (lme function in R) with random effect
of subject, and fixed effects of age, genotype and the age × genotype interaction. We did not model the effect of brain region on PSw and PSg as
the study was not powered to detect region-level effects, especially considering that these may vary with age. Because AD and ageing are known
to preferentially affect hippocampal BBB integrity, effects on hippocampal PSw and PSg were investigated as an exploratory analysis. The mixed-
effects model used for both analyses is appropriate for data with partial repeated measures (i.e. because some but not all 13-month-old animals
had repeat scans at 21 months, and 18-month-old rats were scanned only once). Heteroskedastic errors in levels of the age factor were modelled
to account for differences in measurement variance across age. Tukey post hoc tests were used to assess pairwise effects.
To investigate whether measurements of PSw and PSg were related, linear regression analysis was performed. Separate regression lines were
fit for each age group.
3 | RESULTS
Example VIF, ROIs and model fits are shown in Figure 1. Figure 2 shows correlation and Bland–Altman plots for scan-rescan repeatability mea-
surements. Table 1 shows ROI sizes, volumes, ROI substructures and scan-rescan CoVs. Figure 3 shows point estimates and group mean values
for PSw and PSg measured in the composite ROI across age and genotype. Tables 2 and 3 show the results of the mixed-effects model analyses
and Tukey post hoc tests for composite ROI PSw and PSg. Figure 4 shows measurements of PSw and PSg in individual regions (hippocampus, cor-
tex, thalamus and striatum). Tables 4 and 5 show exploratory mixed-effects model analyses and Tukey post hoc tests for hippocampal PSw and
PSg. Figure 5 shows correlation plots between composite ROI estimates of PSw and PSg.
F IGURE 2 Correlation (A) and Bland–Altman (B) plots showing the agreement between regional scan-rescan measurements of PSw and PSg.
PSw and PSg had coefficient of determination values (R
2) of 0.82 (p < 10−12) and 0.96 (p < 10−16), respectively. Solid lines in the Bland-Altman
plots show the mean difference between scan 1 and scan 2. Dashed lines show the limits of agreement within which 95% of scan-rescan
differences lie. Hipp, hippocampus; Ctx, cortex; Stri, striatum; Thal, thalamus
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3.1 | Scan-rescan repeatability of PSw and PSg
The scan-rescan CoV for the composite ROI was 14% for PSw and 8% for PSg, respectively (Table 1). For individual regions, repeatability of PSw
and PSg was highest in the striatum (CoVR = 13% and 12%, respectively), and lowest in the cortex (CoVR = 38% and 23%, respectively). Figure 2
shows correlation and Bland–Altman plots for scan-rescan data. Scan 1 and scan 2 estimates of PSw and PSg had R
2 values of 0.82 (p < 10−12) and
0.96 (p < 10−16), respectively. Bland–Altman analysis showed that 95% of scan-rescan differences for PSw and PSg were within ±1.5 and 0.086 x
10−3 mL min−1 mL−1, respectively.
The within-group variability (incorporating both measurement error and biological variability) of composite ROI PSw and PSg was 26% and
25%, respectively. Assuming measurement errors and variance due to biological variability add-in quadrature to give the within-group variance,
biological variance in PSw and PSg was estimated to be 21% and 23%, respectively. Thus, the within-group variability was similar for PSw and PSg
and mostly due to biological variation, not random measurement error.
F IGURE 3 Composite region of interest (ROI) estimates of the permeability surface area product of the blood–brain barrier (BBB) to water,
PSw (A) and gadolinium-based contrast agent, PSg (B) for TgF344-AD and wild-type (WT) rats aged 13, 18 and 21 months. Bar heights show the
group means. Points correspond to measurements made in individual rats. Error bars denote standard error of the mean. *statistically significant
pairwise comparisons from Tukey post hoc tests (p < 0.05)
TABLE 2 Mixed-effects model
p-values for PSw and PSg in the composite
region of interest (ROI)
PSw PSg
Age 0.0019 0.22
Genotype 0.0074 0.11
Age × Genotype 0.10 0.28
TABLE 3 Percentage difference and
post hoc Tukey p-values for genotype
and age effects on PSw and PSg in the
composite ROI
Genotype effects (WT vs. TgF344-AD)
PSw PSg
% difference p-value % difference p-value
13 months +14 0.82 −15 0.40
18 months +72 0.012 −10 0.99
21 months +2.9 1.00 +29 0.82
Age effects (WT)
13m vs. 18m −4.9 0.99 +10 0.99
18m vs. 21m +124 0.050 −11 0.99
13m vs. 21m +113 0.042 −2 1.00
Age effects (TgF344-AD)
13m vs. 18m- +43 0.027 +17 0.91
18m vs. 21m +34 0.50 +31 0.71
13m vs. 21m +93 0.047 +53 0.21
Positive percentage differences indicate higher values in TgF344-AD rats (genotype effects) or in older
rats (age effects). Negative percentage differences indicate higher values in wild-types (WTs) (genotype
effects) or in younger rats (age effects). Bold indicates significant effects at the 5% level
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F IGURE 4 Regional estimates of the permeability surface area
product of the blood–brain barrier (BBB) to water, PSw (A) and
gadolinium-based contrast agent, PSg (B) for TgF344-AD and wild-type
(WT) rats aged 13, 18 and 21 months. Bar heights show the group
means. Points correspond to measurements made in individual rats.
Error bars denote standard error of the mean. Ctx, cortex; Hipp,
hippocampus; Stri, striatum; Thal, thalamus
TABLE 4 Mixed-effects model
p-values for PSw and PSg in the
hippocampus
PSw PSg
Age 0.0037 0.46
Genotype 0.023 0.28
Age × Genotype 0.25 0.57
TABLE 5 Percentage difference and
post hoc Tukey p-values for genotype
and age effects on PSw and PSg in the
hippocampus
Genotype effects (WT vs. TgF344-AD)
PSw PSg
% difference p-value % difference p-value
13 months +21 0.91 −7.6 0.96
18 months +64 0.22 −32 0.77
21 months +48 0.59 −0.10 1.0
Age effects (WT)
13m vs. 18m +53 0.65 +2.2 1.0
18m vs. 21m +16 0.99 +1.7 1.0
13m vs. 21m +78 0.47 +3.9 0.99
Age effects (TgF344-AD)
13m vs. 18m +108 0.0026 −24 0.81
18m vs. 21m +5.2 0.99 +48 0.57
13m vs. 21m +119 0.039 +12 0.95
Positive percentage differences indicate higher values in TgF344-AD rats (genotype effects) or in older
rats (age effects). Negative percentage differences indicate higher values in wild-types (WTs) (genotype
effects) or in younger rats (age effects). Bold indicates significant effects at the 5% level
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3.2 | Effects of AD genotype and ageing on PSw and PSg
Mixed-effects analyses (Table 2) showed significant effects of age (p = 0.0019) and genotype (p = 0.0074) on composite ROI PSw, and a borderline
genotype × age interaction (p = 0.10). Tukey post hoc tests (Table 3) showed no difference in composite ROI PSw between TgF344-AD and WTs
at 13 months (p = 0.82). Between 13 and 18 months, TgF344-AD rats exhibited an increase in PSw (43% increase; p = 0.027), leading to higher
PSw relative to WTs at 18 months (72% higher; p = 0.012), as reported previously.
15 Between 18 and 21 months, PSw increased in WTs (124%
increase; p = 0.050), but not in TgF344-AD rats (p = 0.50), abolishing the genotype effect observed at the previous time point (Figure 3A). Mixed-
effects analyses showed that there were no effects of age (p = 0.22), genotype (p = 0.11) or genotype × age (p = 0.28) interactions on composite
ROI PSg (Table 2 and Figure 3B). Post hoc tests also did not show any statistically significant pairwise effects on PSg (Table 3).
As an exploratory analysis we also investigated the effects of age and genotype on hippocampal PSw and PSg. Mixed-effects analyses
(Table 4) showed significant effects of age (p = 0.0037) and genotype (p = 0.023) on hippocampal PSw, and no genotype × age interaction
(p = 0.25). Post hoc tests (Table 5) showed significant age effects only in TgF344-AD rats between 13 and 18 months and between 13 and
21 months. Post hoc tests were unable to detect significant effects of genotype on hippocampal PSw at any age. Mixed-effects analyses and post
hoc tests for hippocampal PSg showed no significant effects of age or genotype.
Figure 4 shows point estimates and group mean values of PSw and PSg in the hippocampus, cortex, striatum and thalamus. Qualitatively, the
effect of age on PSw was largest in the striatum, intermediate in the hippocampus and thalamus, and smallest in the cortex. The effects of geno-
type at 18 months were of similar magnitude in the hippocampus, striatum and thalamus, and smallest in the cortex. The effect of ageing on PSg
was also region dependent. PSg appeared to increase with age in the cortex and thalamus, was static in hippocampus, and appeared to increase
then decrease in the striatum.
Regression analysis showed PSw and PSg were not linearly related (Figure 5). Coefficient of determination (R
2) values for 13-, 18- and
21-month regression lines were all low; R2 = (0.09, 0.05, 0.2), and were not statistically significant (p = 0.12, 0.82 and 0.060, respectively).
4 | DISCUSSION
The effects of AD and ageing on the BBB were investigated in TgF344-AD rats and WTs using MFAME-DCE MRI. We have previously shown
that TgF344-AD rats exhibit higher BBB permeability to water (PSw) at 18 months of age compared with WTs. In the same study, we were unable
to detect higher leakage of a gadolinium-based contrast agent (PSg), indicating that BBB alterations associated with the AD genotype were small,
and not of the level that would lead to substantial leakage of blood-derived proteins into the parenchyma. In this study, we investigated how BBB
PSw and PSg changed with age by scanning at two additional time points: 13 and 21 months. At 13 months of age, we observed no genotype
effect in either PSw or PSg, possibly indicating a lack of detectable AD-related BBB pathology at this time point. Other studies using the same rat
model have shown substantial accumulation of parenchymal and capillary amyloid deposition by this age,27,28 in addition to reduced vascular reac-
tivity28 and functional connectivity.29 Despite these changes, the BBB tight junction protein occludin-1 appears to be maintained.28 Between
13 and 18 months, PSw increased in TgF344-AD but not WTs, leading to the significant genotype effect at 18 months, as previously reported.
Our previous data showed that changes in PSw were correlated with reduced occludin-1 expression in TgF344-AD rats relative to WTs.
15
Between 18 and 21 months, WTs but not TgF344-AD rats exhibited increases in PSw, effectively catching up with AD-related effects that
occurred earlier and abolishing the genotype effect observed at 18 months. The lack of genotype effect at 21 months was unexpected and may
indicate that the upper limit of detection for measurement of PSw was reached. It is known that as the water-exchange rate across the BBB
F IGURE 5 Relationship between composite region of interest
(ROI) estimates of PSw and PSg. Regression analysis was applied
separately to 13-, 18- and 21-month data and did not reveal any
significant trends between PSw and PSg (p > 0.05). The lack of
relationship between PSw and PSg indicates that in the rat model and
age groups studied, blood–brain barrier (BBB) water exchange and
BBB leakage of gadoteric acid occur by different mechanisms
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increases, it becomes experimentally more difficult to measure PSw precisely.
30 This hypothesis is supported by estimates of within-group vari-
ance from our mixed-effects model analyses, which showed that variance in PSw was 2.3 times higher at 21 than at 18 months.
Our results of increased PSw with age agree with a recent multi-TE ASL MRI study conducted by Ohene et al. in young and old
C57B1/6JRj mice.31 Age-related reductions in the water-exchange time (increases in the water-exchange rate) were accompanied by an
increase in aquaporin-4 mRNA expression but a decrease in α-synotrophin mRNA, a protein responsible for anchoring aquaporin-4 to astro-
cyte end feet. Unfortunately, other factors affecting BBB integrity such as tight junction expression were not assessed, making it difficult to
interpret the underlying cause of increased water permeability. Furthermore, the changes in PSw observed in our study are much larger than
in the study by Ohene et al.31 (113% between 13 and 21 months vs. 32% between 7 and 27 months). The reason for this difference is not
clear but may be due to differences in water exchange between species, or it could reflect differences in the MRI method used to quantify
water exchange.
We did not observe effects of age or genotype on PSg. The literature on the effects of AD on BBB leakage of MRI gadolinium-based contrast
agents and other ‘non-essential’ molecules is contradictory; while recent studies have demonstrated an increase in BBB leakage, a similar number
of studies have failed to detect changes in rodent models of AD32,33 and human disease.19,34 Those studies that have detected increased leakage
of gadolinium contrast agents report group-level effects that are much smaller than the within-group variability,12 and thus likely only detectable
using very large sample sizes. In this study, measurement repeatability was similar for PSw and PSg, and it is possible that we were able to detect
differences in PSw but not PSg because water is a much smaller molecule and more likely to be affected by finer scale alterations to BBB function.
To determine whether the degree of BBB water-exchange was related to the degree of BBB gadolinium leakage, we correlated estimates of
PSw and PSg made in the same animal. We did not find evidence of a relationship between the two parameters. In healthy brain, it may be
expected that these parameters are unrelated, because their transport across the BBB is governed by different mechanisms.30 A lack of correla-
tion may also be expected if BBB changes affect one measure but not the other. We know from our previous work that the tight junction protein
occludin-1 is affected from 18 months in this rat model. If these changes were sufficient, it could be expected that PSw and PSg may be related,
since para-cellular diffusion would dominate for both water and contrast agent. However, if these changes were too small to affect the leakage of
gadolinium, then PSw and PSg are still unlikely to be related. Future work should investigate the limits of sensitivity of water-exchange measure-
ments, and determine under which conditions, if any, PSw and PSg are related.
The current study has the following limitations. Measurement of both PSg and PSw within a single examination meant that the protocol for
determining PSg was suboptimal. Compared with a standard DCE-MRI protocol, data between the first pass peak and tail of the gadolinium wash-
out curves were missing, as this time was used to acquire multiflip angle data for PSw estimation. The lack of data during this period may have
increased variability in PSg estimates, making group differences in PSg more difficult to detect experimentally. Further work should determine if
PSg obtained using a standard (full data) DCE-MRI protocol can detect age- and AD-related BBB alterations in this model. The groups studied at
13 and 21 months had an uneven mix of males and females. It is not known whether there are gender differences in BBB integrity in this model.
If present, this may have limited our ability to detect genotype effects at 13 and 21 months. A major limitation is the lack of confirmatory immu-
nohistochemistry, such as staining for tight junction proteins and aquaporin-4. Unfortunately, while the study team extracted brains from all ani-
mals (see the Materials and Methods section), tissue was damaged in storage and did not produce satisfactory staining results. This limits our
ability to understand the microscopic BBB changes governing the observed changes in water permeability. Finally, the small sample size, particu-
larly for the 18- and 21-month-old groups, meant that statistical power was too low to model and test variability in PSw and PSg across multiple
different regions. Regional estimates of PSw and PSg were generated in the hippocampus, cortex, thalamus and striatum, but the variation in PSw
and PSg across regions was not formally evaluated in statistical models or post hoc tests. It is known that AD pathologies vary in severity across
the brain and the use of a composite ROI may have masked regional differences in BBB pathology. We therefore performed an exploratory analy-
sis to determine PSw and PSg alterations in the hippocampus, a region known to be affected early in AD.
4 This analysis showed changes in PSw
between 13 and 18 months and between 13 and 21 months in TgF344-AD rats only. In contrast to the composite ROI, post hoc tests showed no
genotype effects at any time point. In agreement with the composite ROI, no changes in PSg were observed with age or genotype. The lack of hip-
pocampal genotype and WT age effects on PSw are likely because of the absence of striatal and thalamic contributions, which appear to strongly
contribute towards these effects (Figure 4), but could also be due to the lower repeatability of hippocampal measurement due to smaller ROI size
(Table 1).
In conclusion, we have used MFAME-DCE MRI to investigate the effects of age and AD on BBB permeability surface area products of water
and a gadolinium-based contrast agent. We observed increases in BBB PSw with age in both TgF344-AD and WT rats, and found that these
changes occurred earlier in TgF344-AD rats. These results indicate that AD pathology may accelerate the onset of BBB breakdown that occurs as
part of the normal ageing process. Further work is needed to understand the complex structural changes occurring at the BBB that account for
the alterations to PSw observed in this study.
ACKNOWLEDGEMENTS
Purchase of the TgF344 rats was supported by the European Union's Seventh Framework Programme (FP7/2007–2013) under grant agreement
number HEALTH-F2–2011-278,850 (INMiND) and Alzheimer Research UK network funds at the UoM; the breeding and maintenance was jointly
DICKIE ET AL. 9 of 11
supported by EPSRC (EP/M005909/1) and the European Union's Seventh Framework Programme (FP7/2007–2013) under grant agreement
number HEALTH-F2–2011-278,850 (INMiND). The MRI facility is supported through an equipment grant from BBSRC UK (BB/F011350). MRI
scans were funded by the EPSRC (EP/M005909/1).
ORCID
Ben R. Dickie https://orcid.org/0000-0001-5018-2111
Geoff J. M. Parker https://orcid.org/0000-0003-2934-2234
Laura M. Parkes https://orcid.org/0000-0001-6488-507X
REFERENCES
1. Mooradian AD. Effect of aging on the blood-brain barrier. Neurobiol Aging. 1988;9:31-39.
2. Farrall AJ, Wardlaw JM. Blood–brain barrier: ageing and microvascular disease – systematic review and meta-analysis. Neurobiol Aging. 2009;30:
337-352.
3. Erdö F, Denes L, De Lange E. Age-associated physiological and pathological changes at the blood-brain barrier: A review. J Cereb Blood Flow Metab.
2017;37:4-24.
4. Montagne A, Barnes SR, Sweeney MD, et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296-302.
5. Sweeney MD, Montagne A, Sagare AP, et al. Vascular dysfunction—The disregarded partner of Alzheimer's disease. Alzheimers Dement. 2019;15:
158-167.
6. Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol.
2018;14:133-150.
7. Zipser BD, Johanson CE, Gonzalez L, et al. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging. 2007;28:
977-986.
8. Ryu JK, Mcsarnon JG. A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain. J Cell Mol Med.
2009;13:2911-2925.
9. Donahue JE, Flaherty SL, Johanson CE, et al. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol. 2006;112:405-415.
10. Deane R, Bell RD, Sagare A, Zlokovic B. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's dis-
ease. CNS Neurol Disord Drug Targets. 2009;8:16-30.
11. Miller MC, Tavares R, Johanson CE, et al. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res. 2008;1230:
273-280.
12. Nation D, Sweeney M, Montagne A, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25:
270-276.
13. Yamazaki Y, Shinohara M, Shinohara M, et al. Selective loss of cortical endothelial tight junction proteins during Alzheimer's disease progression. Brain.
2019;142:1077-1092.
14. Carrano A, Hoozemans JJM, van der Vies SM, Rozemuller AJM, van Horssen J, de Vries HE. Amyloid beta induces oxidative stress-mediated blood–
brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal. 2011;15:1167-1178.
15. Dickie BR, Vandesquille M, Ulloa J, Boutin H, Parkes LM, Parker GJM. Water-exchange MRI detects subtle blood-brain barrier breakdown in
Alzheimer's disease rats. Neuroimage. 2019;184:349-358.
16. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid
angiopathy and Alzheimer's disease. Brain Pathol. 2008;18:253-266.
17. Iliff JJ, Wang M, Liao Y, et al. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes,
Including Amyloid. Sci Transl Med. 2012;4(147):147ra111. https://doi.org/10.1126/scitranslmed.3003748
18. Zeppenfeld DM, Simon M, Haswell JD, et al. Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging
brains. JAMA Neurol. 2017;74:91-99.
19. van de Haar HJ, Burgmans S, Jansen JFA, et al. Blood-brain barrier leakage in patients with early Alzheimer disease. Radiology. 2016;281:
527-535.
20. Bowman GL, Dayon L, Kirkland R, et al. Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement.
2018;14:1640-1650.
21. Kilkenny C, Browne W, Cuthill I, et al. Animal research: Reporting in vivo experiments: The ARRIVE guidelines. British J Pharmacol. 2010;1577-1579.
22. Voigt T, Nehrke K, Doessel O, Katscher U. T1 corrected B1 mapping using multi-TR gradient echo sequences. Magn Reson Med. 2010;64:725-733.
23. Schwarz AJ, Danckaert A, Reese T, et al. A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatom-
ical atlas: Application to pharmacological MRI. Neuroimage. 2006;32:538-550.
24. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood
Flow Metab. 1983;3:1-7.
25. Sourbron SP, Buckley DL. On the scope and interpretation of the Tofts models for DCE-MRI. Magn Reson Med. 2011;66:735-745.
26. Hyslop NP, White WH. Estimating precision using duplicate measurements. J Air Waste Manag Assoc. 2009;59:1032-1039.
27. Cohen RM, Rezai-Zadeh K, Weitz TM, et al. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric A, and frank
neuronal loss. J Neurosci. 2013;33:6245-6256.
28. Joo IL, Lai AY, Bazzigaluppi P, et al. Early neurovascular dysfunction in a transgenic rat model of Alzheimer's disease. Sci Rep. 2017;7:1-14.
29. Anckaerts C, Blockx I, Summer P, et al. Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model
of Alzheimer's Disease: A longitudinal MRI study. Neurobiol Dis. 2019;124:93-107.
30. Dickie BR, Parker GJM, Parkes LM. Measuring water exchange across the blood-brain barrier using MRI. Prog Nucl Magn Reson Spectrosc. 2020;116:
19-39.
10 of 11 DICKIE ET AL.
31. Ohene Y, Harrison IF, Evans PG, et al. Increased blood–brain barrier permeability to water in the aging brain detected using noninvasive multi-TE ASL
MRI. Magn Reson Med. 2020:1-8.
32. Gustafsson S, Gustavsson T, Roshanbin S, et al. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6
immunotherapy. Neuropharmacology. 2018;143:1-9.
33. Bien-Ly N, Boswell CA, Jeet S, et al. Lack of widespread BBB disruption in Alzheimer's disease models: Focus on therapeutic antibodies. Neuron.
2015;88:289-297.
34. Wang H, Golob EJ, Su MY. Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and
cerebellum of patients with MCI and normal controls. J Magn Reson Imaging. 2006;24:695-700.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Supporting Information section at the end of this article.
How to cite this article: Dickie BR, Boutin H, Parker GJM, Parkes LM. Alzheimer's disease pathology is associated with earlier alterations
to blood–brain barrier water permeability compared with healthy ageing in TgF344-AD rats. NMR in Biomedicine. 2021;34:e4510. https://
doi.org/10.1002/nbm.4510
DICKIE ET AL. 11 of 11
